Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya

PHASE2,PHASE3

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped Scientific review positive from 3 manufacturers; internal committees did not support due to deploying new flu vaccines in HIV+ pregnant women in Kenya.

Conditions

Influenza, Human
HIV
Malaria
Tetanus
Polio

Interventions

BIOLOGICAL: Quadrivalent Inactivated Influenza Vaccine (QIV)
BIOLOGICAL: Inactivated Polio Vaccine
BIOLOGICAL: Double Dose QIV

Sponsor

Centers for Disease Control and Prevention